Unicycive Therapeutics In... (UNCY)

AI Score

Unlock

0.64

0.00 (0.00%)

At close: Apr 25, 2025, 10:00 AM

Unicycive Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net Income	-21.52M	-4.1M	3.93M	-20.96M	-7.8M	-4.33M	-3.84M	-14.57M	-5.33M	-5.56M	-3.64M	-3.54M	-2.75M	-5.2M	-1.1M	-964K	-880K	-702K	-338K	-344K	-702K	-564K	-449.5K	-449.5K
Depreciation & Amortization	134K	123K	-113K	284K	82K	79K	78K	45K	42K	40K	40K	39K	1K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	582K	605K	641K	522K	550K	929K	144K	144K	197K	266K	294K	290K	231K	239K	294K	202K	71K	70K	60K	31K	24K	n/a	n/a	n/a
Other Working Capital	731K	-3.5M	108K	1.07M	694K	-1.19M	-1.16M	193K	-375K	-266K	325K	227K	430K	-1.72M	45K	-99K	12K	-82K	-3K	-25K	-15K	115K	-51.5K	-51.5K
Other Non-Cash Items	12.56M	-1.75M	-10.88M	12.08M	1.89M	-1.4M	-282K	10.38M	21K	-1.65M	406K	307K	-91K	2.77M	441K	271K	239K	208K	155K	137K	244K	347K	188.5K	188.5K
Deferred Income Tax	n/a	n/a	n/a	n/a	-287K	n/a	n/a	n/a	n/a	1.65M	-406K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	1.7M	-4.13M	108K	1.89M	1.12M	299K	-1.6M	91K	-1.02M	1.69M	255K	251K	1.21M	-1.28M	148K	-182K	32K	-282K	-19K	103K	-15K	115K	-51.5K	-51.5K
Operating Cash Flow	-6.55M	-9.25M	-6.32M	-6.46M	-4.44M	-4.42M	-5.5M	-3.92M	-6.08M	-3.56M	-3.05M	-2.96M	-1.4M	-3.47M	-217K	-673K	-538K	-706K	-142K	-73K	-449K	-102K	-312.5K	-312.5K
Capital Expenditures	-22K	-24K	-20K	-6K	n/a	n/a	-12K	n/a	-2K	n/a	n/a	-2K	-29K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-22K	-24K	-20K	-6K	n/a	n/a	-12K	n/a	-2K	n/a	n/a	-2K	-29K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	174K	701K	501K	860K	49K	10K	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	-13.09B	13.09B	n/a	-11.66B	10.32B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	-1.09M	-208K	-867K	n/a	n/a	-192K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	365K	-157K	284K	-496K	-205K	-51K	n/a	-2.39M	-482K	n/a	n/a	n/a	18.72M	21.48M	-103K	119K	-25K	-92K	92K	50K	463K	102K	300.5K	300.5K
Financial Cash Flow	365K	-157K	-811K	45.69M	-205K	-51K	n/a	27.8M	-471K	n/a	n/a	n/a	n/a	21.48M	71K	820K	475K	768K	141K	60K	463K	102K	300.5K	300.5K
Net Cash Flow	-6.21M	-9.43M	-7.15M	39.23M	-4.64M	-4.47M	-5.51M	23.88M	-6.55M	-3.56M	-3.05M	-2.96M	-1.43M	18.01M	-146K	147K	-63K	62K	-1K	-13K	14K	n/a	-12K	-12K
Free Cash Flow	-6.57M	-9.28M	-6.34M	-6.46M	-4.44M	-4.42M	-5.51M	-3.92M	-6.09M	-3.56M	-3.05M	-2.96M	-1.43M	-3.47M	-217K	-673K	-538K	-706K	-142K	-73K	-449K	-102K	-312.5K	-312.5K